Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Prev Post Triumph Gold Announces the Acquisition of the Coyote Knoll Silver-Gold Mineral Property – Located in Central Utah June 4, 2025 Next Post S&P 500 Bullish Patterns: Are Higher Highs Ahead? June 4, 2025 Related Posts Fortune Bay Announces Option Agreement for the Woods Uranium Projects August 5, 2025 Diggers and Dealers 2025 Presentation August 5, 2025 Sarama Provides Update on Arbitration Proceedings August 5, 2025